[1]
|
Fujii, Y.R. (2010) RNA genes: Retroelements and virally retroposable microRNAs in human embryonic stem cells. The Open Virology Journal, 4, 63-75.
doi:10.2174/1874357901004010063
|
[2]
|
Lin, S.L. and Ying, S.Y. (2013) Gene silencing in vitro and in vivo using intronic microRNAs. Methods in Molecular Biology, 936, 209-229.
|
[3]
|
Khraiwesh, B., Arif, M.A., Seumel, G.I., Ossowski, S., Weigel, D., Reski, R. and Frank, W. (2009) Transcriptional control of gene expression by microRNAs. Cell, 140, 111-122. doi:10.1016/j.cell.2009.12.023
|
[4]
|
Raver-Shapira, N., Marciano, E., Meiri, E., Spector, Y., Rosenfeld, N., Moskovits, N., Benhwich, Z. and Oren, M. (2007) Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Molecular Cell, 26, 731-743.
doi:10.1016/j.molcel.2007.05.017
|
[5]
|
Lin, S.-L. and Ying, S.-Y. (2013) Mechanism and Method for generating tumor-free iPS cells using intronic micro RNA miR-302 induction. In: Ying, S.-Y., Ed., MicroRNA Protocols. 2nd Edition, Humana Press, Springer, New York, 295-312.
|
[6]
|
Sharma, A. and Wu, J.C. (2013) MicroRNA expression profiling of human-induced pluripotent and embryonic stew cells. In: Ying, S.-Y., Ed., MicroRNA Protocols. 2nd Edition, Humana Press, Springer, New York, 247-256.
doi:10.1007/978-1-62703-083-0_19
|
[7]
|
Wang, J. and Yang, X. (2012) The function of miRNA in cardiac hypertrophy. Cellular Molecular Life Science, 69, 3561-3570. doi:10.1007/s00018-012-1126-y
|
[8]
|
Wang, K., Zhang, S., Marzolf, B., Troisch, P., Brightman, A., Hu, Z., Hood, L.E. and Galas, D.J. (2009) Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proceedings of the National Academy of Sciences, 106, 4402-4407. doi:10.1073/pnas.0813371106
|
[9]
|
Turchinovich, A., Weiz, L., Langheinz, A. and Burwinkel, B. (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Research, 39, 7223-7233.
doi:10.1093/nar/gkr254
|
[10]
|
Vickers, K.C., Palmisano, B.T., Shoucri, B.M., Shamburek, R.D. and Remaley, A.T. (2011) MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nature Cell Biology, 13, 423-435. doi:10.1038/ncb2210
|
[11]
|
Gibbings, D.J., Ciaudo, C., Erhardt, M. and Voinnet, O. (2009) Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nature Cell Biology, 11, 1143-1151.
|
[12]
|
Wang, X., Tang, S., Le, S.Y., Lu, R., Rader, J.S., Meyer, C. and Zheng, Z.-M. (2008) Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One, 3, e2557.
|
[13]
|
Wang, X., Wang, H.-K., Mccoy, J.P., Banerjee, N.S., Rader, J.S., Broker, T.R., Meyers, C., Chow, L.T. and Zheng, Z.-M. (2009) Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA, 15, 637-647.
doi:10.1261/rna.1442309
|
[14]
|
Meckes Jr., D.G., Shair, K.H.Y., Marquitz, A.R., Kung, C.-P., Edwards, R.H. and Raab-Traub, N. (2010) Human tumor virus utilizes exosomes for intercellular communication. Proceedings of the National Academy of Sciences, 107, 20370-20375. doi:10.1073/pnas.1014194107
|
[15]
|
Fujii, Y.R. (2008) Fromulation of new algorithmics for mi RNAs. The Open Virology Journal, 2, 37-43.
doi:10.2174/1874357900802010037
|
[16]
|
Astolfi, P.A., Salamini, F. and Sgaramella, V. (2010) Are we genomic mosaics? Variations of the genome of somatic cells can contribute to diversity our phenotypes. Current Genomics, 11, 379-386.
doi:10.2174/138920210793175949
|
[17]
|
Wissing, S., Muo?z-Lopez, M., Macia, A., Yang, Z., Montano, M., Collins, W., Garcia-Perez, J.L., Moran, J.V. and Greene. W.C. (2012) Reprogramming somatic cells into iPS cells activates LINE-1 retroelement mobility. Human Molecular Genetics, 21, 208-218.
doi:10.1093/hmg/ddr455
|
[18]
|
Lin, S.L., Chang, D.C., Chang-Lin, S., Lin, C.H., Wu, D.T., Chen, D.T. and Ying, S.Y. (2008) Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA, 14, 2115-2124. doi:10.1261/rna.1162708
|
[19]
|
Anokye-Danso, F., Trivedi, C.M., Juhr, D., Gupta, M., Cui, Z., Tian, Y., Zhang, Y. Yang, W., Gruber, P.J., Epstein, J.A. and Morrisey, E.E. (2011) Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell, 8, 376-388.
doi:10.1016/j.stem.2011.03.001
|
[20]
|
Wang, J. and Yang, X. (2012) The function of miRNA in cardiac hypertrophy. Cellular Molecular Life Sciences, 69, 3561-3570. doi:10.1007/s00018-012-1126-y
|
[21]
|
Macfarlan, T.S., Gifford, W.D., Driscoll, S., Lettier, K., Rowe, H.M., Bonanomi, D., Firth, A., Singer, O., Trono, D. and Pfaff, S.L. (2012) Embryonic stem cell potency fluctuates with endogenous retrovirus activity. Nature, 487, 57-65. doi:10.1038/nature11244
|
[22]
|
Séralini, G.E., Clair, E., Mesnage, R., Gress, S., Defarge, N., Malatesta, M., Hennequin, D. and de Vend?mois, J.S. (2012) Long term toxicity of a roundup herbicide and a roundup-tolerant generally modified maize. Food Chemical Toxicology, 50, 4221-4231.
doi:10.1016/j.fct.2012.08.005
|
[23]
|
Chrupek, M., Siipi, H. and Martinelli, L. (2012) Bio-objects as “boundary crawlers”: The case of microRNA. Croat Medical Journal, 53, 285-288.
doi:10.3325/cmj.2012.53.285
|
[24]
|
Jiang, M., Sang, X. and Horg, Z. (2012) Beyond nutrients: Food-derived microRNAs provide cross-kingdom regulation. Bioassays, 34, 280-284.
doi:10.1002/bies.201100181
|
[25]
|
Zhang, L., Hou, D., Chen, X., Donghai, L., Zhu, L., Zhang, L., Li, J., Bian, Z., Liang, X., Cai, X., Yin, Y., Wang, C., Zhang, T., Zhu, D., Zhang, D., Xu, J., Chen, Q., Ba, Y., Liu, J., Wang, Q., Chen, J., Wang, J. Wang, M., Zhang, Q., Zhang, J., Zen, K. and Zhang, C.-Y. (2012) Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Research, 22, 207-126.
doi:10.1038/cr.2011.158
|
[26]
|
Garinot, M., Fievenz, V., Pourcelle, V., Stoffelbach, F., des Rieux, A., Plapied, L., Theate, I., Freichels, H., Jerome, C., Marchand-Brynaert, J., Schneider, Y.J. and Préat, V. (2007) PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination. Journal of Controlled Release, 120, 195-204.
doi:10.1016/j.jconrel.2007.04.021
|
[27]
|
Sureban, S.M., May, R., Mondalek, F.G., Qu, D., Ponnurangam, S., Pantazis, P., Anant, S., Ramanujam, R.P. and Houchen, C.W. (2011) Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism. Journal of Nanobiotechnology, 9, 40.
doi:10.1186/1477-3155-9-40
|
[28]
|
Fujii, Y.R. (2009) Oncoviruses and pathogenic micro-RNAs in humans. The Open Virology Journal, 3, 37-51.
|